acquisitionMSD grabs Eyebiotech Ltd for US$1.3bn upfrontLatest NewsUS pharma giant Merck Sharp & Dohme (MSD) is decided to acquire London-based ophtalmology expert Eyebiotech Ltd for upt to US$3bn., US$1.7bn in future milestones. Read more 30 May 2024 https://european-biotechnology.com/wp-content/uploads/2024/06/Fundus_-_diabetic_retinopathy.png 857 1009 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-05-30 06:24:272024-07-07 09:36:01MSD grabs Eyebiotech Ltd for US$1.3bn upfront